Delivery Order SPE2DB22D2006-SPE2DB25FW3CQ
- Not listed
- The Defense Logistics Agency awarded a $3,011.25 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 200-unit vials of Botox, with an ultimate completion date of August 19, 2025. The contract, which was competitively awarded with no set-aside designation, is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of BOTOX 100 unit vials with a ceiling value of $1,722.72. This firm fixed price delivery order represents a non-set-aside competitive award with an ultimate completion date of August 25, 2025. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $10,257.48 delivery order to AmerisourceBergen Drug Corp for BOTOX 200 unit vials on July 28, 2025, with an ultimate completion date of August 18, 2025. This is a firm fixed price, non-set-aside contract performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $12,821.85 to AmerisourceBergen Drug Corp for the supply of BOTOX 200 unit vials. This firm fixed price contract was competitively awarded without set-aside designation and is scheduled for completion by August 18, 2025. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $1 billion comprehensive pharmaceutical supply vehicle...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Botox 100 unit vials valued at $10,336.32. This firm fixed-price delivery order, with a completion date of August 11, 2025, will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. The contract was awarded without a set-aside designation, indicating open competition. This delivery order is a child contract issued under AmerisourceBergen...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order worth $11,642.60 to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The contract is for the delivery of 200 unit BOTOX vials to a location in Conshohocken, Pennsylvania by March 19, 2024. This award is part of Amerisourcebergen Drug Corp's role as the prime contractor on an indefinite delivery contract (IDC) with DLA, valued at up to...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,787.40 to AmerisourceBergen Drug Corp for Botox Cosmetic 100 unit vials under a firm fixed-price contract. The award was made on September 23, 2025, with an ultimate completion date of October 15, 2025. This non-set-aside, competitively awarded delivery order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a routine pharmaceutical procurement...
- The Defense Logistics Agency awarded a $3,445.44 firm fixed price delivery order to AmerisourceBergen Drug Corp for 100-unit vials of Botox. This competitive award, issued on July 14, 2025, with an ultimate completion date of August 4, 2025, represents a child order under AmerisourceBergen's larger indefinite delivery contract (IDC) with DLA Troop Support Medical. The work will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. No set-aside designation was...
- The Defense Logistics Agency awarded a $4,306.80 delivery order to AmerisourceBergen Drug Corp for the supply of Botox 100 unit vials, with an ultimate completion date of August 25, 2025. This is a firm fixed-price, non-set-aside contract with performance taking place in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026,...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for $3,011.25 to supply 200-unit vials of BOTOX. The contract was competitively awarded without a set-aside designation and is structured as a firm fixed price delivery order with an ultimate completion date of August 26, 2025. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania serves as the place of performance. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- SPE2DB22D2006Indefinite Delivery Contract
- SPE2DB22D2006-SPE2DB25FW3CQDelivery Order
The Defense Logistics Agency (DLA) awarded a $2,584.08 delivery order to AmerisourceBergen Drug Corp for Botox 100 Unit Vials, with an ultimate completion date of August 26, 2025. This competitively awarded, firm fixed-price contract uses no set-aside designation and is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs worldwide. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement through the DLA's Medical Supply Chain. The company maintains an extensive portfolio of pharmaceutical products and medical supplies supporting Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. This specific delivery order for Botox represents one of numerous competitively awarded transactions the vendor fulfills under its prime IDC, demonstrating its capability to meet federal procurement requirements across a diverse range of therapeutic domains and product categories.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.6k | 8/5/25 |